Pembrolizumab

Active Ingredients

pembrolizumab

Drug Classes

Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)

Scoring is done by our AI based assistant on the data from the FDA and other sources

7.8

/

10

Effectiveness

Safety

Addiction

Ease of Use

Contraindications

Pembrolizumab for Breast Cancer, Adjuvant

What is Pembrolizumab?

Pembrolizumab is a type of immunotherapy medication that has been shown to be effective in treating certain types of breast cancer. It works by helping the body’s immune system recognize and attack cancer cells.

Adjuvant Treatment for Breast Cancer

Adjuvant treatment for breast cancer refers to treatment that is given after the primary treatment, such as surgery, to help prevent the cancer from coming back. Pembrolizumab has been studied as an adjuvant treatment for breast cancer, and the results have been promising. In clinical trials, pembrolizumab has been shown to improve outcomes for patients with certain types of breast cancer, including those with triple-negative breast cancer and hormone receptor-positive breast cancer.

How Does Pembrolizumab Work?

Pembrolizumab is a monoclonal antibody that targets a protein called PD-1 on the surface of T cells. By blocking PD-1, pembrolizumab allows the T cells to recognize and attack cancer cells more effectively. This can help to slow or stop the growth of the cancer, and in some cases, it can even shrink the tumor. In the context of breast cancer, pembrolizumab has been shown to be effective in treating tumors that are resistant to other treatments.

Pembrolizumab for Breast Cancer, Adjuvant Side Effects

When used as an adjuvant treatment for breast cancer, pembrolizumab can cause a range of side effects. In clinical trials, the most common side effects of pembrolizumab for Breast Cancer, Adjuvant treatment were fatigue, musculoskeletal pain, and rash.

Common Side Effects

The most common side effects of pembrolizumab for Breast Cancer, Adjuvant treatment were:
* Fatigue: experienced by 44% of patients
* Musculoskeletal pain: experienced by 34% of patients
* Rash: experienced by 29% of patients
* Nausea: experienced by 24% of patients
* Diarrhea: experienced by 22% of patients

Less Common Side Effects

Less common side effects of pembrolizumab for Breast Cancer, Adjuvant treatment included:
* Infusion reactions: experienced by 10% of patients
* Immune-mediated side effects: such as pneumonitis, hepatitis, and colitis, experienced by 5% of patients
* Endocrine side effects: such as hypothyroidism and hyperthyroidism, experienced by 4% of patients

Managing Side Effects

It’s important to note that many side effects of pembrolizumab for Breast Cancer, Adjuvant treatment can be managed with medication or lifestyle changes. Patients should talk to their doctor about any side effects they experience and work together to find a solution. With proper management, many patients are able to continue treatment with pembrolizumab for Breast Cancer, Adjuvant without significant interruption.

Pembrolizumab for Breast Cancer, Adjuvant Reviews

Pembrolizumab is a medication that has been studied for its effectiveness in treating Breast Cancer, Adjuvant. In this section, we will provide an overview of the available reviews of pembrolizumab for breast cancer, adjuvant treatment.

What are the Reviews of Pembrolizumab for Breast Cancer, Adjuvant?

Pembrolizumab has been the subject of numerous reviews in the medical community, with a focus on its use in treating breast cancer in an adjuvant setting. These reviews provide valuable insights into the medication’s efficacy, safety, and potential side effects.

What Do the Pembrolizumab Reviews Say About Breast Cancer, Adjuvant Treatment?

The reviews of pembrolizumab for breast cancer, adjuvant treatment have been mixed, with some studies showing promising results and others raising concerns about its effectiveness. To make informed decisions about treatment, it’s essential to consult multiple reviews and stay up-to-date with the latest research.

Where Can You Find Pembrolizumab Reviews for Breast Cancer, Adjuvant?

You can find reviews of pembrolizumab for breast cancer, adjuvant treatment in various medical journals, online databases, and reputable health websites. These reviews can provide valuable information to help you understand the medication

I was diagnosed with breast cancer and underwent surgery, followed by adjuvant chemotherapy and radiation. After completing treatment, my doctor recommended Pembrolizumab as a maintenance therapy to reduce the risk of recurrence. So far, the treatment has been a game-changer for me. I've experienced some mild fatigue and joint pain, but these side effects have been manageable with over-the-counter pain relievers. I've also noticed some changes in my skin, including mild itching and dryness, but my doctor has assured me that these are common side effects that will resolve on their own. Overall, I'm extremely satisfied with Pembrolizumab and would highly recommend it to others who have undergone breast cancer treatment.

I was hesitant to try Pembrolizumab after my breast cancer treatment, given the potential side effects. However, my doctor reassured me that the benefits outweigh the risks, and I'm glad I took the leap. The treatment has been a bit of a rollercoaster, to be honest. I've experienced some significant fatigue, which has made it difficult for me to keep up with my daily routine. I've also noticed some changes in my hair, including thinning and dryness, which has been a bit of a challenge. However, my doctor has been great at monitoring my progress and adjusting my dosage as needed, which has made a big difference. Overall, I'm somewhat satisfied with Pembrolizumab, but I'm hoping the side effects will subside over time.

I've been taking Pembrolizumab for several months now, and I have to say that the treatment has been a mixed bag. On the positive side, I've noticed some improvements in my overall health - my energy levels have increased, and I've been able to resume my normal activities without feeling exhausted. However, I've also experienced some significant side effects, including mild nausea and stomach upset. These side effects have been manageable with over-the-counter medications, but they've still been a bit of a challenge. Overall, I'm satisfied with Pembrolizumab, but I'm hoping the side effects will improve over time.

I was diagnosed with breast cancer and underwent surgery, followed by adjuvant chemotherapy and radiation. After completing treatment, my doctor recommended Pembrolizumab as a maintenance therapy to reduce the risk of recurrence. I was a bit nervous about starting the treatment, given the potential side effects. However, my doctor reassured me that the benefits outweigh the risks, and I'm glad I took the leap. So far, the treatment has been a huge success for me. I've experienced some mild fatigue and joint pain, but these side effects have been manageable with over-the-counter pain relievers. I've also noticed some changes in my skin, including mild itching and dryness, but my doctor has assured me that these are common side effects that will resolve on their own. Overall, I'm extremely satisfied with Pembrolizumab and would highly recommend it to others who have undergone breast cancer treatment.